Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Aird

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Chemotherapy and Pharmacology|February 24, 2005
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175R L Hayward, Q C Schornagel, R Tente, et al.
Clinical Endocrinology|December 1, 1977
Renal bone disease--what is it and why does it happen?T G Feest, M K Ward, H A Ellis, et al.
Journal of the American Chemical Society|February 2, 2006
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditionsAnna F A Peacock, Abraha Habtemariam, Rafael Fernández, et al.
Journal of Medicinal Chemistry|October 19, 2001
Inhibition of cancer cell growth by ruthenium(II) arene complexesR E Morris, R E Aird, P del S Murdoch, et al.
NPJ Regenerative Medicine|September 30, 2024
Utilising an in silico model to predict outcomes in senescence-driven acute liver injuryCandice Ashmore-Harris, Evangelia Antonopoulou, Rhona E Aird, et al.
Journal of Medicinal Chemistry|December 13, 2006
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligandsAbraha Habtemariam, Michael Melchart, Rafael Fernandez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Gut|March 23, 2025
Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescenceDaniel Rodrigo-Torres, Alastair M Kilpatrick, Sofia Ferreira-Gonzalez, et al.
Mucosal Immunology|April 13, 2017
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammationG-T Ho, R E Aird, B Liu, et al.
Journal of Hepatology|January 4, 2025
Host hepatocyte senescence determines the success of hepatocyte transplantation in a mouse model of liver injuryVictoria L Gadd, Sofia Ferreira-Gonzalez, Tak Yung Man, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|February 24, 2005
Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175R L Hayward, Q C Schornagel, R Tente, et al.
Clinical Endocrinology|December 1, 1977
Renal bone disease--what is it and why does it happen?T G Feest, M K Ward, H A Ellis, et al.
Journal of the American Chemical Society|February 2, 2006
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditionsAnna F A Peacock, Abraha Habtemariam, Rafael Fernández, et al.
Journal of Medicinal Chemistry|October 19, 2001
Inhibition of cancer cell growth by ruthenium(II) arene complexesR E Morris, R E Aird, P del S Murdoch, et al.
NPJ Regenerative Medicine|September 30, 2024
Utilising an in silico model to predict outcomes in senescence-driven acute liver injuryCandice Ashmore-Harris, Evangelia Antonopoulou, Rhona E Aird, et al.
Journal of Medicinal Chemistry|December 13, 2006
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligandsAbraha Habtemariam, Michael Melchart, Rafael Fernandez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancerE R Brown, K A Charles, S A Hoare, et al.
Gut|March 23, 2025
Longitudinal paired liver biopsies and transcriptome profiling in alcohol-associated hepatitis reveal dynamic changes in cellular senescenceDaniel Rodrigo-Torres, Alastair M Kilpatrick, Sofia Ferreira-Gonzalez, et al.
Mucosal Immunology|April 13, 2017
MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammationG-T Ho, R E Aird, B Liu, et al.
Journal of Hepatology|January 4, 2025
Host hepatocyte senescence determines the success of hepatocyte transplantation in a mouse model of liver injuryVictoria L Gadd, Sofia Ferreira-Gonzalez, Tak Yung Man, et al.
Pageof 3